ACA
Avoro Capital Advisors Portfolio holdings
AUM
$5.71B
This Quarter Return
+82.66%
1 Year Return
+11.37%
3 Year Return
+255.37%
5 Year Return
+558.9%
10 Year Return
+18,722.72%
AUM
$5.06B
AUM Growth
+$5.06B
(+71%)
Cap. Flow
+$550M
Cap. Flow
% of AUM
10.87%
Top 10 Holdings %
Top 10 Hldgs %
66.41%
Holding
49
New
8
Increased
18
Reduced
13
Closed
5
Top Buys
Top Sells
| 1 |
PTC Therapeutics
PTCT
|
$44.4M |
| 2 |
SAGE
Sage Therapeutics
SAGE
|
$28.7M |
| 3 |
TCDA
Tricida, Inc. Common Stock
TCDA
|
$21M |
| 4 |
ZGNX
Zogenix, Inc.
ZGNX
|
$14.9M |
| 5 |
ATNX
Athenex, Inc. Common Stock
ATNX
|
$14.1M |
Sector Composition
| 1 | Healthcare | 80.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMMU
1
DELISTED
Immunomedics Inc
IMMU
| $930M | 18.39% | 26,250,000 +1,750,000 | +7% | +$62M |
|
|
MRTX
2
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $489M | 9.68% | 4,286,765 +174,065 | +4% | +$19.9M |
|
|
HZNP
3
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $333M | 6.59% | 6,000,000 +1,425,000 | +31% | +$79.2M |
|
4
Iovance Biotherapeutics
IOVA
$807M
| $284M | 5.62% | 10,361,039 +1,350,626 | +15% | +$37.1M |
|
5
Sarepta Therapeutics
SRPT
$1.78B
| $269M | 5.31% | 1,675,000 +90,000 | +6% | +$14.4M |
|
6
Ascendis Pharma
ASND
$11.8B
| $259M | 5.12% | 1,750,000 -37,000 | -2% | -$5.47M |
|
7
BioMarin Pharmaceuticals
BMRN
$11.2B
| $228M | 4.51% | 1,850,000 -80,000 | -4% | -$9.87M |
|
8
argenx
ARGX
$43.6B
| $218M | 4.32% | 970,000 +33,500 | +4% | +$7.55M |
|
|
MYOK
9
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $182M | 3.59% | 1,880,000 +445,000 | +31% | +$43M |
|
10
Amicus Therapeutics
FOLD
$2.34B
| $166M | 3.28% | 11,000,000 +50,000 | +0.5% | +$754K |
|
11
Adverum Biotechnologies
ADVM
$64.6M
| $158M | 3.13% | 7,585,000 +435,000 | +6% | +$9.08M |
|
12
Mersana Therapeutics
MRSN
$36.5M
| $152M | 3.01% | +6,500,000 | New | +$152M |
|
13
Karyopharm Therapeutics
KPTI
$61.7M
| $133M | 2.62% | 7,000,000 | – | – |
|
|
CNST
14
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $120M | 2.38% | 4,000,000 +350,000 | +10% | +$10.5M |
|
|
DCPH
15
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $111M | 2.2% | 1,860,000 -140,000 | -7% | -$8.36M |
|
|
ADAP
16
Adaptimmune Therapeutics
ADAP
$15.6M
| $100M | 1.98% | +10,000,000 | New | +$100M |
|
|
XLRN
17
DELISTED
Acceleron Pharma Inc.
XLRN
| $99.1M | 1.96% | 1,040,000 +180,000 | +21% | +$17.1M |
|
18
uniQure
QURE
$896M
| $67.6M | 1.34% | 1,500,000 -150,000 | -9% | -$6.76M |
|
19
Relmada Therapeutics
RLMD
$37.2M
| $63.8M | 1.26% | 1,425,000 +275,000 | +24% | +$12.3M |
|
|
ZGNX
20
DELISTED
Zogenix, Inc.
ZGNX
| $60.8M | 1.2% | 2,250,000 -550,000 | -20% | -$14.9M |
|
|
ARNA
21
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $59.8M | 1.18% | +950,000 | New | +$59.8M |
|
|
ATNX
22
DELISTED
Athenex, Inc. Common Stock
ATNX
| $53M | 1.05% | 3,850,000 -1,025,000 | -21% | -$14.1M |
|
23
Allogene Therapeutics
ALLO
$251M
| $48.3M | 0.96% | 1,128,594 | – | – |
|
24
Cue Biopharma
CUE
$60M
| $45.8M | 0.91% | 1,870,000 | – | – |
|
25
Madrigal Pharmaceuticals
MDGL
$9.76B
| $39.6M | 0.78% | 350,000 +1,000 | +0.3% | +$113K |
|